Is Pfizer Stock Undervalued?

Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in the range of $61 billion to $64 billion, and its adjusted earnings to be in the range of $2.80 and $3.00 per share. This compares with our …

This post was originally published on this site

Marketing block

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Sign Up for Updates

Get the latest stock market news from Phil by signing up for our newsletter!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Is Pfizer Stock Undervalued?

Marketing block

Recent Posts

Media Consolidation

What does 2025 hold for interest rates, inflation and the American consumer?

The Future of Syria and Turkey’s Role

Killing the budget bill let China off the hook (shared)

Ranked: The World’s 10 Largest Companies by Revenue

Microsoft Bundling Practices Focus of Federal Antitrust Probe

Sign Up for Updates